Alnylam Pharmaceuticals
Stacy Beal serves as the Associate Director of Portfolio Management at Alnylam Pharmaceuticals since June 2023 and is also the Head of Strategy at Bodhi Consulting, LLC, starting in September 2022. Previous roles include Senior Manager of Technical Development Strategic Operations at Moderna, Capital Project Manager at Finlays, Principal Engineer at Raytheon Integrated Defense, and Process Engineer IV at Alexion Pharmaceuticals, among others. Stacy's educational background includes a Certificate of Accomplishment in Immunology from Harvard Medical School in 2021, a Master's degree in Engineering/Industrial Management from Penn State University (2017-2019), and a degree from Worcester Polytechnic Institute (2003-2006).
This person is not in any teams
This person is not in any offices
Alnylam Pharmaceuticals
31 followers
Alnylam is the world's leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market.